Evidence map›Paper›PMID 34719043›Full record

ArticleEquine veterinary journal2022

Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations.

Taisuke Kuroda, Yohei Minamijima, Motoi Nomura, Shozo Yamashita, Masayuki Yamada, Shunichi Nagata, Hiroshi Mita, Norihisa Tamura, Kentaro Fukuda, Atsutoshi Kuwano and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Equine veterinary journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Taisuke KurodaClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.ORCID https://orcid.org/0000-0002-3709-5459
Yohei MinamijimaDrug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Japan.ORCID https://orcid.org/0000-0002-2096-0784
Motoi NomuraEquine Department Main office, Japan Racing Association, Minato-ku, Japan.
Shozo YamashitaDrug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Japan.
Masayuki YamadaDrug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Japan.
Shunichi NagataDrug Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Japan.
Hiroshi MitaClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Norihisa TamuraClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.ORCID https://orcid.org/0000-0002-9138-6839
Kentaro FukudaClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Atsutoshi KuwanoClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Kanichi KusanoEquine Department Main office, Japan Racing Association, Minato-ku, Japan.ORCID https://orcid.org/0000-0003-3722-9135
Pierre-Louis ToutainComparative Biomedical Sciences, The Royal Veterinary College, London, UK.ORCID https://orcid.org/0000-0002-8846-8892
Fumio SatoClinical Veterinary Medicine Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Japan.
Japan Racing Association · JPLaboratory of Racing Chemistry · JPRoyal Veterinary College · GB

Funding

Japan Racing Association
6 · The paper itself

Abstract

backgroundFor medication control in several jurisdictions, withdrawal time is the period of refrain from racing after drug administration. It is set by adding a safety period to an experimental detection time. However, there are no reports of statistical analyses of detection time for the determination of withdrawal time in flunixin meglumine-treated horses.

objectiveTo analyse the population pharmacokinetics of flunixin in horses through the generation of a dataset for detection time statistical analysis and predictions via Monte Carlo simulation. STUDY

designExperimental study.

methodsDrug plasma and urine concentrations following single intravenous administration of flunixin 1.1 mg/kg bodyweight (BW) in 10 horses and multiple administration of q 24 hours for 5 days in 10 horses were measured using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Data were modelled using a nonlinear mixed effect model followed by Monte Carlo simulation. Irrelevant plasma concentration (IPC) and irrelevant urine concentration (IUC) were calculated using the Toutain approach. Detection times were obtained considering the time after the last administration for selected quantiles of 5000 hypothetical horses under the international screening limit (ISL) proposed by the International Federation of Horseracing Authorities (plasma: 1 ng/mL, urine; 100 ng/mL).

resultsFor a regimen of 1.1 mg/kg BW q 24 hours, the IPC and IUC values were 2.0 and 73.0 ng/mL respectively. Detection times in plasma above the ISL for 90% of simulated horses were estimated as 74 hours after a single 1.1 mg/kg dose administration, 149 and 199 hours after multiple doses over 5 days at either 24- or 12-hour intervals respectively. Corresponding detection times in urine were 46, 68 and 104 hours respectively. MAIN LIMITATION: Only female horses were investigated.

conclusionsStatistical detection times for different flunixin meglumine regimens indicated a delay of detection time in plasma after multiple administrations under ISL.

Indexed as

ClonixinTandem Mass SpectrometryAnimalsAnti-Inflammatory Agents, Non-SteroidalChromatography, LiquidFemaleHorsesMonte Carlo MethodAnti-Inflammatory Agents, Non-SteroidalClonixinflunixindopinghorseirrelevant plasma concentrationirrelevant urine concentrationmedication control

Identifiers

PMID34719043
PMCPMC9546317
OpenAlexW3210208045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.